RESEARCHER PROFILE

Jonathan D. Smith

← Back to Case Western Reserve University

J

Case Western Reserve University

Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular HealthCardiac electrophysiology and arrhythmiasAtrial Fibrillation Management and Outcomes

Jonathan D. Smith works in Cholesterol and Lipid Metabolism, Atherosclerosis and Cardiovascular Diseases, Lipoproteins and Cardiovascular Health, Cardiac electrophysiology and arrhythmias, Atrial Fibrillation Management and Outcomes. Recorded institutional associations include Cleveland Clinic, Lund University, AbbVie (United States).

519Publications
37,007Citations
83H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

    2011 · 5,576 citations
  2. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis

    2013 · 4,372 citations
  3. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

    1992 · 2,261 citations
  4. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

    2000 · 1,044 citations
  5. Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides

    1996 · 887 citations
  6. ApoE Promotes the Proteolytic Degradation of Aβ

    2008 · 874 citations
  7. Multi-ethnic genome-wide association study for atrial fibrillation

    2018 · 771 citations
  8. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

    2004 · 737 citations
  9. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.

    1995 · 724 citations
  10. Meta-analysis identifies six new susceptibility loci for atrial fibrillation

    2012 · 599 citations
  11. γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO

    2014 · 545 citations
  12. Common variants in KCNN3 are associated with lone atrial fibrillation

    2010 · 485 citations
  13. Genome-wide association study of PR interval

    2010 · 438 citations
  14. High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport

    2012 · 393 citations
  15. An abundant dysfunctional apolipoprotein A1 in human atheroma

    2014 · 364 citations
  16. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse

    1997 · 346 citations
  17. Vineland Adaptive Behavior Scales

    2012 · 346 citations
  18. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation

    2017 · 343 citations
  19. Alcohol Consumption Raises HDL Cholesterol Levels by Increasing the Transport Rate of Apolipoproteins A-I and A-II

    2000 · 321 citations
  20. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P 1 to limit vascular inflammation

    2015 · 314 citations
  21. Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks

    2013 · 303 citations
  22. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

    1995 · 278 citations
  23. Characterization of Clone 13, a Naturally Attenuated Avirulent Isolate of Rift Valley Fever Virus, which is Altered in the Small Segment

    1995 · 273 citations
  24. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β peptides

    2000 · 272 citations
  25. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex

    2013 · 268 citations

← Return to the university profile